Zika virus (ZIKV) viremia is reported as low and transient; however, these estimates rely on limited data. We report RNA loads in sera collected from symptomatic patients during the 2013-2014 French Polynesian ZIKV outbreak. We performed molecular detection of ZIKV RNA in sera from 747 patients presenting with suspected acute phase ZIKV infection. Among patients with confirmed infection, we analyzed the duration of viremia, assessed viral RNA loads and recorded the main clinical symptoms. A total of 210/747 (28.1%) sera tested positive using a ZIKV-specific RT-PCR. Viral RNA loads in symptomatic patients that ranged from 5 to 3.7 × 10 6 copies/mL (mean 9.9 × 10 4 copies/mL) were not related to a particular clinical presentation, and were significantly lower than those previously obtained from asymptomatic ZIKV infected blood donors. The rate of detection of ZIKV RNA in sera from suspected cases of acute phase ZIKV infection was low. ZIKV RNA loads were lower in symptomatic patients compared to asymptomatic blood donors and were lower than RNA loads usually reported in dengue infections. As there is no abrupt onset of symptoms in ZIKV infections, we suggest that infected patients sought for medical attention when viremia was already decreasing or had resolved.
Zika virus (ZIKV) viremia is reported as low and transient; however, these estimates rely on limited data. We report RNA loads in sera collected from symptomatic patients during the 2013-2014 French Polynesian ZIKV outbreak. We performed molecular detection of ZIKV RNA in sera from 747 patients presenting with suspected acute phase ZIKV infection. Among patients with confirmed infection, we analyzed the duration of viremia, assessed viral RNA loads and recorded the main clinical symptoms. A total of 210/747 (28.1%) sera tested positive using a ZIKV-specific RT-PCR. Viral RNA loads in symptomatic patients that ranged from 5 to 3.7 × 10 6 copies/mL (mean 9.9 × 10 4 copies/mL) were not related to a particular clinical presentation, and were significantly lower than those previously obtained from asymptomatic ZIKV infected blood donors. The rate of detection of ZIKV RNA in sera from suspected cases of acute phase ZIKV infection was low. ZIKV RNA loads were lower in symptomatic patients compared to asymptomatic blood donors and were lower than RNA loads usually reported in dengue infections. As there is no abrupt onset of symptoms in ZIKV infections, we suggest that infected patients sought for medical attention when viremia was already decreasing or had resolved. Clinical manifestations of ZIKV infection mainly consist of maculopapular rash, arthralgia/myalgia, low fever, asthenia, headache, and conjunctivitis, 7 as reported in French Polynesia, 21 Yap, 22 and
Brazil.
At the time of the study, the recommendation for acute phase ZIKV infection was based on molecular detection of ZIKV RNA during the acute phase of infection using reverse transcription (RT)-PCR in blood samples collected within the first week post-symptom onset (PSO). 7, 24 Since then, this recommendation has been enlarged to the second week PSO, and serodiagnosis is also performed if RT-PCR is negative. 25 Serology-based diagnosis is limited by the cross-reactivity of antibodies developed in response to infections with other flaviviruses, especially dengue virus (DENV) 7, 25 and requires confirmation by sero-neutralization tests which can only be performed by highly trained and specialized laboratories. 4, 7 However, crossreactivity has been observed even using sero-neutralization assays, especially in secondary arbovirus infections. 24 In French Polynesia, as most of the patients were previously infected by DENV, ZIKV serodiagnosis was not implemented. 26 ZIKV viremia is usually reported as low and transient, making diagnosis by RT-PCR a challenge. 4, 27 We report the data obtained using molecular based detection of ZIKV RNA from suspected cases of ZIKV infections and levels of ZIKV RNA loads observed for confirmed ZIKV infection cases.
These viral loads were compared with those previously published for asymptomatic ZIKV RNA positive blood donors in French Polynesia. 28 
| METHODS
The study was conducted in French Polynesia from October 2013 to All statistical analyses were performed with the GraphPad Prism 6 software, using Mann-Whitney test.
| RESULTS
Characteristics of the studied population are reported in Fig. 1 ZIKV RNA loads were assessed in 57 sera found positive by RT-PCR for which remaining sera was available (Supplemental Table S1 ). Detailed results for number of days PSO, and clinical data (fever, rash, asthenia, conjunctivitis, arthralgia/myalgia) were available for 42 patients.
ZIKV RNA loads that ranged from 5 to 3.7 × 10 6 copies/mL (mean 9.9 × 10 4 copies/mL) were not significantly different between males and females (P = 0.21) and between patients aged under and over 18 years (P = 0.12) ( Table 2) and were not significantly different from patients presenting with and without fever, rash, asthenia, conjunctivitis, or arthralgia/myalgia (Table 3 ). In contrast, ZIKV RNA loads were significantly lower compared to ZIKV RNA loads from 26 asymptomatic French Polynesian blood donors that were previously published (RNA loads ranging from 2.5 × 10 3 to 8.1 × 10 6 copies/mL, mean 7.3 × 10 5 copies/mL) (P < 0.0001) (Supplemental Table S2 ). 28 The analysis of ZIKV RNA loads from five blood donors that became symptomatic post-donation (ranging from 3 × 10 3 to 5.2 × 10 6 , mean 1.1 × 10 6 copies/mL) showed no significant difference with those obtained from the 21 blood donors who remained asymptomatic (P = 0.95), but they were significantly higher than those found in symptomatic patients (P = 0.004).
| DISCUSSION
Among the cases suspected to have ZIKV infection, only 28.1% tested positive for detection of both partial M/E and E ZIKV encoding genes.
While patients presented with symptoms compatible with a ZIKV infection and tested negative for DENV, the high rate of equivocal and negative results may be explained by the low sensitivity of our method which may have been responsible for false negative results. Another explanation is the timing of symptom development relative to ZIKV viremia in serum with a potential delay between development of viremia and symptom onset. Indeed by the time patients developed symptoms and sought for medical attention, ZIKV viremia may have resolved in blood and RNA cleared in serum.
The sensitivity of our method was the same as previously reported on sera tested in Yap, 4 estimated at 25 and 100 copies per assay for partial M/E and E encoding genes, respectively. 29 As previously reported, using the same primers and probes, ZIKV RNA was more frequently detected in saliva than in blood collected at the same time during acute phase ZIKV infection, but the use of saliva did not increase the window of detection of ZIKV RNA. 31 A study conducted from persons with travel-associated ZIKV disease concluded that urine also increased the rate of ZIKV RNA detection during the acute phase of infection and extended the window of ZIKV RNA detection. 32 Our results and those previously published 32 suggest that, during the first days PSO, the higher detection rates by RT-PCR in urine and saliva compared to blood are probably related to higher ZIKV RNA loads in these fluids, suggesting that a higher sensitivity could be reached during the acute phase of ZIKV infection by testing urine or saliva instead of blood. Though the most important challenge to ZIKV diagnosis is the short window during which RNA can be detected in serum.
In contrast to other mosquito-borne diseases such as dengue, there is no abrupt onset of clinical symptoms in ZIKV infections. 7 In dengue, flushing is common on day 1 or 2 post-onset of fever and rash usually appears between day 2 and 6 after onset of fever. 33, 34 DENV viremia peaks at day 2 before defervescence of fever, and only one third of infected patients have detectable RNA at the end of the febrile phase. 35 Fever is not a prominent feature of ZIKV infection, is low grade, and is not the main cause of consultation as reported in French Polynesia and in Brazil. 7, 23 In French Polynesia, patients usually sought for medical attention during rash. Consequently, ZIKV infected patients might have sought for medical care later in the acute phase of infection and at that time, viremia was already decreasing or resolved. The finding that ZIKV RNA loads were significantly higher in pre-symptomatic blood donors compared to the 57 symptomatic patients confirms that blood samples from ZIKV infected symptomatic patients were probably collected during the resolving phase of viremia. Data about ZIKV RNA loads in symptomatic patients are scarce and rely on studies conducted in Yap 4 and from case reports, 14, 20, [36] [37] [38] [39] with viral loads in blood up to 7.2 × 10 5 copies/mL. In Nicaraguan patients, the mean viral RNA load was 5.4 × 10 3 and 1.1 × 10 5 copies/mL in non pregnant patients and | 1507 pregnant women, respectively. 40 In French Polynesia, the ZIKV RNA loads detected in blood samples collected from symptomatic patients (ranging from 5 to 3.7 × 10 6 copies/mL) were lower than the viral loads usually reported during DENV infection (ranging from 10 5 to 10 9 copies/mL). 35 Viral loads in asymptomatic and symptomatic patients infected with arboviruses are available for chikungunya (CHIKV) and West Nile (WNV) viruses. For CHIKV, viral loads (expressed in pfu/mL) were not significantly higher in symptomatic patients than in asymptomatic blood donors. 41 For WNV, a study conducted in 821 blood donors with confirmed WNV infection showed that 26% of WNV RNA positive patients developed symptoms and had higher RNA loads at index donation compared to those who remained asymptomatic. 42 It was previously reported that WNV RNA persists in blood compartments with detection of RNA in whole blood samples collected up to 3 months post-index donation in ∼40% of blood donors who tested positive for WNV RNA in plasma at the time of blood donation. 43 Despite a trend for symptomatic WNV-positive donors to maintain higher levels of WNV RNA in whole blood compared to asymptomatic WNV-positive donors, the difference was not statistically significant. 43 For ZIKV, RNA loads were found higher in asymptomatic blood donors 28 than in symptomatic ZIKV-infected patients, but there was no difference in the levels of viral loads at the time of blood donation between blood donors who remained asymptomatic compared to those who developed symptoms.
In dengue, viral loads were found significantly higher in dengue hemorrhagic fever compared to dengue fever in some studies studies, [44] [45] [46] and not different in others. 47, 48 However, high DENV viral loads appear to correlate with the severity of the disease. Equivocal results were probably related to low RNA loads at the time of blood collection rather than false positive results for the detection of partial M/E or E encoding genes.
| CONCLUSION
In symptomatic ZIKV-infected patients, the low rate of detection of ZIKV RNA in serum can be explained by low viral loads, delayed consultation due to mildness of symptoms, and delayed development of symptoms in patients that probably sough for health care provider attention while viremia was resolving in blood. At the acute phase of ZIKV infection, the detection rate of ZIKV RNA by RT-PCR in serum is low compared to urine and saliva. Consequently, ZIKV infection should never be excluded on the basis of a negative RT-PCR in serum, and saliva and urine samples should be also tested. 
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